Metraipolis › archive › dc_102cec4c92fd
ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting — Europe PMC PMID:41561063
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41561063
- DOI
- 10.3389/fendo.2025.1706091
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:21:38.808Z
- SHA-256 of the archived text
da40eaccdf23af25745adbaff3a29f5f50a0c35036b9b5cbbe9def6b630af470- Stable URL of this page
https://metraipolis.com/documento/dc_102cec4c92fd
How to cite
ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting — Europe PMC PMID:41561063 — Europe PMC (en), https://europepmc.org/article/MED/41561063 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_102cec4c92fd (Metraipolis archive dc_102cec4c92fd, sha256 da40eaccdf23af25745adbaff3a29f5f50a0c35036b9b5cbbe9def6b630af470)
BibTeX
@misc{dc102cec4c92fd,
title = {ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting — Europe PMC PMID:41561063},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41561063},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_102cec4c92fd; sha256 da40eaccdf23af25745adbaff3a29f5f50a0c35036b9b5cbbe9def6b630af470},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41561063. Agents can read the archived copy with the MCP tool read_document.